Amphiphilic poly-N-vinylpyrrolidones: Synthesis, properties and liposome surface modification

Biomaterials

Volumn 22, Issue 22, 2001, Pages 3035-3044

  Torchilin, V P ^a   Levchenko, T S ^a   Whiteman, K R ^a   Yaroslavov, A A ^b   Tsatsakis, A M ^c   Rizos, A K ^b   Michailova, E V ^d   Shtilman, M I ^d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF CRETE   (Greece)

^d MENDELEEV UNIVERSITY OF CHEMICAL TECHNOLOGY OF RUSSIA   (Russian Federation)

Author keywords

Amphiphilic poly(vinyl pyrrolidone); Fluorescence quenching; Liposome stability in serum; Liposomes; Micellization; Steric protection

Indexed keywords

AGENTS; FLUORESCENCE; FREE RADICAL POLYMERIZATION; HYDROPHILICITY; HYDROPHOBICITY; LIPIDS; MICELLES; POLYMERS;

STERRIC PROTECTORS;

BIOMATERIALS;

DRUG CARRIER; LIPOSOME; POLYMER; POVIDONE; POVIDONE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL MODIFICATION; FLUORESCENCE; MICELLE; MOLECULAR SIZE; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SURFACE PROPERTY; SYNTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG STABILITY; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROSTATICS; FLUORESCENT DYES; LIPOSOMES; MATERIALS TESTING; MICE; MICELLES; POVIDONE; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 0035889821     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(01)00050-3     Document Type: Article

References (51)

1. Biodegradable long-circulating polymeric nanospheres
2. Polymer-coated long-circulating microparticulate pharmaceuticals
3. The mechanism of liposome accumulation in infarction
4. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
5. Tumor vascular permeability and the EPR effect in macromolecular therapeutics; a review
6. Liposome circulation time and targeting; implication for cancer chemotherapy
7. Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
8. Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer
9. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium
10. Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes; factors influencing targeted accumulation in the infarcted myocardium
11. Which polymers can make nanoparticular drug carriers long-circulating?
12. Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation; studies with poly(ethylene glycol)-coated vesicles
13. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
14. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo
15. Stealth liposomes; an improved sustained release system for 1-β-D-arabinofuranosylcytosine
16. The role of surface charge and hydrophilic groups on liposome clearance in vivo
17. Molecular mechanism of the lipid vesicle longevity in vivo
18. How do polymers prolong circulation time of liposomes
19. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes
20. Surface-modified liposomes; assessment and characterization for increased stability and prolonged blood circulation
21. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration in mice
22. Serum opsonins and liposomes; their interaction and opsonophagocytosis
23. Pharmacokinetics of long-circulating liposomes
24. Fate and behavior of liposomes in vivo; a review of controlling factors
25. Separation of large unilamellar liposomes from blood components by a spin column procedure; towards identifying plasma proteins which mediate liposome clearance in vivo
26. Association of blood proteins with large unilamellar liposomes in vivo; relation to circulation lifetimes
27. Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro
28. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system
29. Why do polyethylene glycol-coated liposomes circulate so long?
30. Poly(ethylene glycol) on the liposome surface; on the mechanism of polymer-coated liposome longevity
31. Effect of polymers attached to lipid headgroups on properties of liposomes
32. Final report of the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, -20M
33. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates
34. Chemistry of polyethylene glycol conjugates with biologically active molecules
35. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo
36. New synthetic amphiphilic polymers for steric protection of liposomes in vivo
37. New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes
38. Phosphatidyl polyglycerols prolong liposome circulation in vivo
39. Indication to prescription of blood and blood substitutes in operative medicine
40. Effect of povidone-iodine on wound healing; a review
41. Synthesis and polymerization of a styryl terminated oligovinylpyrrolidone macromonomer
42. Negatively charged vesicles coated by poly(oxyethylene) layer; interaction with polycations